Arbutus Biopharma Corpora...
(ABUS)
undefined
undefined%
At close: undefined
3.42
0.29%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Revenue | 18.14M | 39.02M | 10.99M | 6.91M | 6.01M | 5.90M | 10.70M | 1.50M | 24.87M | 15.00M | 15.46M | 14.18M | 16.30M | 21.35M | 13.78M | 9.64M | 15.92M | 13.60M | 13.29M | 12.17M | 2.73M | 5.07M | 3.46M | 1.77M | 1.14M | 1.23M |
| Cost of Revenue | 73.70M | 1.43M | 1.75M | 47.48M | 57.60M | 57.90M | 62.70M | 61.30M | 51.51M | 38.70M | 21.46M | 18.13M | 19.49M | 22.13M | 16.97M | 13.25M | n/a | 6.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -55.56M | 37.59M | 9.23M | -40.57M | -51.59M | -52.00M | -52.00M | -59.80M | -26.63M | -23.70M | -5.99M | -3.94M | -3.19M | -779.12K | -3.19M | -3.61M | 15.92M | 7.42M | 13.29M | 12.17M | 2.73M | 5.07M | 3.46M | 1.77M | 1.14M | 1.23M |
| Operating Income | -78.10M | -65.46M | -73.52M | -57.81M | -144.07M | -89.80M | -110.90M | -491.60M | -102.32M | -33.00M | -12.15M | -12.99M | -10.32M | -12.51M | -9.07M | -10.95M | 2.64M | -1.68M | -5.96M | -27.63M | -34.65M | -27.72M | -16.41M | -9.20M | -8.17M | -8.75M |
| Interest Income | 5.69M | 2.19M | 127.00K | 741.00K | 2.11M | 3.00M | 1.54M | 1.39M | 674.00K | 853.00K | 540.00K | 138.95K | 122.28K | 106.94K | 156.33K | 738.37K | 1.02M | 316.81K | 439.39K | 750.85K | 1.14M | 1.02M | 1.03M | n/a | n/a | n/a |
| Pretax Income | -72.85M | -65.01M | -76.25M | -63.74M | -166.38M | -61.40M | -108.70M | -489.10M | -77.31M | -38.70M | -14.06M | 29.95M | -9.85M | -12.52M | -9.48M | -11.72M | -2.58M | 18.08M | -7.67M | -29.80M | n/a | n/a | -15.96M | n/a | n/a | n/a |
| Net Income | -72.85M | -69.46M | -77.35M | -65.21M | -153.72M | -57.10M | -84.40M | -384.10M | -61.12M | -38.80M | -14.06M | 29.95M | -9.73M | -12.41M | -9.33M | -11.72M | -2.58M | 18.08M | -8.06M | -28.05M | -34.08M | -26.79M | -14.02M | -9.20M | -8.17M | -8.75M |
| Selling & General & Admin | 22.48M | 17.83M | 17.14M | 14.72M | 17.73M | 16.00M | 16.10M | 39.40M | 26.44M | 8.70M | 5.55M | 26.89M | 6.18M | 4.78M | 3.97M | 3.62M | 4.44M | 3.85M | 3.78M | 7.76M | 6.78M | 5.52M | 3.10M | 2.25M | 1.57M | 1.33M |
| Research & Development | 73.70M | 84.41M | 65.50M | 47.48M | 57.60M | 57.90M | 62.70M | 61.30M | 51.51M | 38.70M | 21.46M | 18.13M | n/a | 22,134.00B | n/a | n/a | 8.43M | 4.53M | 8.76M | 22.32M | 23.71M | 21.61M | 12.85M | 8.72M | 7.75M | 8.65M |
| Other Expenses | n/a | 2.23M | 1.87M | 1.98M | 2.03M | 7.30M | 2.20M | 2.50M | -770.00K | -5.80M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 96.24M | 102.24M | 82.64M | 64.18M | 77.36M | 76.10M | 80.80M | 101.80M | 78.53M | 47.90M | 27.62M | -19.49M | 7.14M | 11.73M | 5.88M | 4.73M | 13.28M | 9.10M | 14.38M | 35.55M | 37.38M | 32.79M | 19.87M | 10.97M | 9.31M | 9.98M |
| Interest Expense | 459.00K | 1.73M | 2.86M | 4.01M | 2.11M | 200.00K | 261.00K | n/a | n/a | n/a | n/a | 47.00K | 76.91K | n/a | n/a | n/a | n/a | 1.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 96.24M | 102.24M | 82.64M | 64.18M | 77.36M | 76.10M | 80.80M | 101.80M | 78.53M | 47.90M | 27.62M | -19.49M | 26.63M | 33.86M | 22.85M | 17.98M | 13.28M | 15.29M | 14.38M | 35.55M | 37.38M | 32.79M | 19.87M | 10.97M | 9.31M | 9.98M |
| Income Tax | n/a | 4.44M | 1.10M | 1.47M | -12.66M | -4.30M | -24.30M | -105.00M | -16.18M | 100.00K | 1.91M | 3.72M | -590.69K | -99.82K | 259.76K | 3.38M | 0.00 | -2.31K | 388.32K | 8.95M | -483.80K | -852.14K | -2.33M | 0.00 | 0.40 | 0.03 |
| Shares Outstanding (Basic) | 165.96M | 150.94M | 106.24M | 75.84M | 57.09M | 55.30M | 54.69M | 53.05M | 45.45M | 21.58M | 15.29M | 13.73M | 11.32M | 10.33M | 10.33M | 8.12M | 4.77M | 3.86M | 7.71M | 7.70M | 7.13M | 6.57M | 5.07M | 4.93M | 2.82M | 2.16M |
| Shares Outstanding (Diluted) | 165.96M | 150.94M | 106.24M | 75.84M | 57.09M | 55.30M | 54.72M | 53.05M | 45.46M | 22.44M | 15.30M | 14.32M | 11.32M | 10.33M | 10.33M | 8.12M | 4.77M | 3.86M | 7.71M | 7.70M | 7.13M | 6.57M | 5.07M | 4.93M | 2.82M | 2.16M |
| EPS (Basic) | -0.44 | -0.46 | -0.73 | -0.86 | -2.69 | -1.03 | -1.54 | -7.24 | -1.34 | -1.8 | -0.92 | 2.16 | -0.86 | -1.2 | -0.9 | -1.44 | -0.54 | 4.68 | -1.04 | -3.64 | -4.78 | -4.08 | -2.76 | -1.87 | -2.9 | -4.05 |
| EPS (Diluted) | -0.44 | -0.46 | -0.73 | -0.86 | -2.69 | -1.03 | -1.54 | -7.24 | -1.34 | -1.73 | -0.92 | 2.07 | -0.86 | -1.2 | -0.9 | -1.44 | -0.54 | 4.68 | -1.04 | -3.64 | -4.78 | -4.08 | -2.76 | -1.87 | -2.9 | -4.05 |
| EBITDA | -70.99M | -61.86M | -71.64M | -57.81M | -147.32M | -58.95M | -106.44M | -488.07M | -76.72M | -32.44M | -11.54M | 34.18M | -9.06M | -11.05M | -6.74M | -7.23M | 3.05M | 20.97M | 1.31M | -17.90M | -27.76M | -22.06M | -12.57M | -9.41M | -6.87M | -7.76M |
| Depreciation & Amortization | 1.40M | 1.43M | 1.75M | 1.98M | 2.03M | 2.18M | 2.03M | 1.09M | 589.00K | 500.00K | 612.84K | 869.54K | 955.45K | 1.04M | 1.91M | 1.11M | 411.65K | 599.77K | 2.40M | 1.20M | 6.80M | 5.59M | 3.85M | 1.26M | 1.30M | 989.78K |